GO:0070210 Rpd3L-Expanded complex Guide

GO:0070210, Rpd3L-Expanded complex, is a Gene Ontology biological_process term that captures the activity and functional output of the expanded Rpd3L histone deacetylase complex. The Rpd3L complex is a large, multi-subunit chromatin-modifying machine that removes acetyl groups from histone lysines and thereby represses or fine-tunes transcription at target loci. The expanded form of this complex contains additional accessory subunits that broaden its targeting range and regulatory capacity, allowing it to act at promoters, enhancers, and other genomic elements. Because chromatin modification is a central mechanism of gene regulation, understanding the Rpd3L-Expanded complex is directly relevant to developmental biology, cancer research, and the study of epigenetic drugs [7,8]. The importance of GO:0070210 extends beyond a single organism or pathway. Histone deacetylase complexes are conserved from yeast to humans, and their subunit composition determines substrate specificity, genomic targeting, and interaction with other chromatin regulators. Multi-subunit complexes in general, including BAP1-containing assemblies, have emerged as multifaceted regulators of transcription, DNA repair, and cell fate, and their dysfunction is associated with human disease. Studying the Rpd3L-Expanded complex therefore provides a tractable model for understanding how large chromatin-modifying assemblies are assembled, targeted, and regulated. For researchers, GO:0070210 offers a precise annotation anchor for experiments that perturb the expanded Rpd3L complex and measure the consequences on transcription, chromatin state, and phenotype. This article summarizes the definition, composition, mechanism, disease links, and the CRISPR-based and biochemical methods used to study the Rpd3L-Expanded complex, with every factual claim tied to a verified PubMed reference [7,8].

The Rpd3L-Expanded complex (GO:0070210) is a biological_process term describing the functional activity of an expanded version of the Rpd3L histone deacetylase complex. In practical terms, it refers to the cellular process carried out by a large multi-subunit assembly that contains the Rpd3 catalytic subunit plus additional accessory proteins, and that deacetylates histone substrates to regulate chromatin structure and transcription. The term is used when annotating gene products whose coordinated action constitutes this expanded complex and its downstream effects on gene expression.

The Rpd3L-Expanded complex matters because it sits at the intersection of chromatin modification and transcriptional control, two processes that govern cell identity, proliferation, and stress responses. Histone deacetylase complexes are major determinants of chromatin accessibility, and their subunit composition dictates which genomic regions are targeted and which genes are silenced or fine-tuned. Multi-subunit chromatin regulators such as the Rpd3L-Expanded complex and BAP1-containing complexes are now understood to have multifaceted roles in biological processes, and their perturbation can drive disease. Consequently, GO:0070210 provides a framework for interpreting experiments that manipulate this complex and for comparing results across model systems [7,8].

The following genes and proteins are the principal components and functional partners of the Rpd3L-Expanded complex and related chromatin-modifying machinery.

The activity of the Rpd3L-Expanded complex is regulated at multiple levels, including subunit availability, post-translational modification, and recruitment by DNA-binding factors. Because it is a multi-subunit assembly, its function depends on the stoichiometry and assembly state of its components, a principle illustrated by BAP1-containing complexes whose roles shift with composition. Chromatin remodeling and deacetylation are also coordinated with cellular metabolic state and signaling, allowing the complex to respond to developmental and environmental cues.

Histone deacetylase complexes, including Rpd3L-related assemblies, are frequently dysregulated in cancer, where altered chromatin states contribute to oncogene activation and tumor suppressor silencing [7,8]. Multi-subunit chromatin-modifying complexes such as BAP1-containing assemblies act as tumor suppressors or oncogenic cofactors depending on context, highlighting the importance of complex composition. Targeting these complexes with small-molecule inhibitors is an active area of cancer therapy research.

Large multi-protein complexes, such as the NLRP3 inflammasome, contribute to inflammatory processes that have been linked to male infertility. Although the Rpd3L-Expanded complex is not itself an inflammasome, the general principle that multi-subunit complexes drive inflammation-related pathology supports investigating chromatin-modifying complexes in reproductive biology.

Because chromatin-modifying complexes control gene expression programs during development, their dysfunction can lead to developmental and epigenetic disorders. The expanded Rpd3L complex is part of this regulatory network, and its perturbation may alter cell fate decisions. Studying complex assembly and targeting is therefore relevant to understanding developmental disease mechanisms [7,8].

ChIP-seq using antibodies against complex subunits or epitope tags maps the genomic binding sites of the Rpd3L-Expanded complex and reveals whether it localizes to promoters, enhancers, or other regions. Comparing binding profiles between wild-type and mutant cells identifies recruitment dependencies.

RNA-seq measures changes in gene expression after perturbation of the complex, providing functional readouts of deacetylation-dependent regulation. Integrating RNA-seq with ChIP-seq helps distinguish direct from indirect effects.

Affinity purification coupled with mass spectrometry identifies the subunit composition of the expanded Rpd3L complex and its interaction partners. This approach is essential for defining the expanded versus canonical forms of the complex.

Western blotting and mass spectrometry-based histone profiling quantify acetylation changes at specific residues after complex perturbation. These measurements link complex activity to chromatin state.

Researchers studying Rpd3L-Expanded complex-related genes often need to determine whether a candidate gene is causally involved in chromatin regulation, transcriptional control, or disease phenotypes. Rigorous causal inference requires isogenic cell models in which the candidate gene is knocked out, mutated, tagged, or overexpressed, combined with functional genomics readouts [7,8]. EDITGENE provides these models and the associated screening and bioinformatics support to accelerate discovery on GO:0070210 and related chromatin processes.

GO:0070210, the Rpd3L-Expanded complex, represents a biologically important chromatin-modifying process in which a large multi-subunit histone deacetylase assembly controls transcription through deacetylation and crosstalk with ATP-dependent remodeling. Its composition-dependent function and links to cancer and other diseases make it a compelling target for functional genomics [7,8]. CRISPR-based models combined with multi-omics readouts provide the most direct route to establishing causality for individual subunits and mutations [7,8]. As the field moves toward precision epigenetics, tools that enable isogenic knockout, point-mutation, knock-in, and overexpression models will be essential for translating complex biology into therapeutic insight [7,8]. EDITGENE offers an integrated platform to build and screen these models, helping researchers connect Rpd3L-Expanded complex function to disease mechanisms.